Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogenic adipose-derived mesenchymal stem cells (Aarhus University Hospital)
- Development stage
- Unknown
- Lead developer
- Skejby Sygehus
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
Allogenic adipose-derived mesenchymal stem cells (AD-MSCs) are a cell therapy product developed by Aarhus University Hospital for the treatment of knee osteoarthritis. These cells are harvested from the adipose tissue of healthy donors (typically undergoing cosmetic surgery), expanded in vitro, cryopreserved, and delivered via a single intra-articular injection. The therapy leverages the immunomodulatory and anti-inflammatory properties of mesenchymal stem cells to alter the joint environment. By secreting a variety of bioactive factors and cytokines, the AD-MSCs aim to reduce synovial inflammation, alleviate pain, and potentially promote tissue repair in patients with mild-to-moderate knee osteoarthritis.
- Other names
- Allogenic AD-MSCAllogenic Mesenchymal Stem Cell Intraarticular InjectionAllogenic adipose derived mesenchymal stem cells
Beyond the preview
Go deeper on allogenic adipose-derived mesenchymal stem cells (Aarhus University Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogenic adipose-derived mesenchymal stem cells (Aarhus University Hospital).